Swiss pharma lags behind in global innovation ranking
Pharmaceutical companies are currently among the most innovative firms in the world alongside tech and software giants such as Apple and Alphabet, according to the Boston Consulting Group (BCG). But Swiss pharma companies rank low in their latest Top 50 list.
This content was published on
2 minutes
Keystone-SDA/swissinfo/sb
Español
es
La farmacéutica suiza se rezaga en ranking de innovación
“Pharma companies performed strongly this year, joining technology and software companies that have dominated the rankings in recent years,” said BCG in a statementExternal link on Thursday. The group have released their “Most Innovative Companies 2021” report that features a Top 50 ranking.
In 2021, nine pharmaceutical companies were ranked by BCG experts among the 50 most innovative companies, three times more than the previous year.
US pharmaceutical companies Pfizer and Johnson & Johnson, which have developed vaccines against Covid-19, were ranked the 10th and 20th most innovative firms. Abbott Labs (29th) and Merck & Co (35th) also featured highly in the table that was topped by Apple, Alphabet, Amazon, Microsoft and Tesla.
Swiss pharmaceutical giants Novartis and Roche, which did not launch any Covid vaccines, were ranked 36th and 48th most innovative firms, respectively. They were nonetheless ahead of the British-Swedish multinational AstraZeneca (49th) and the German firm Bayer (50th).
More
More
The Swiss Connection Podcast: Hear Swiss science stories for the world
Why is Switzerland so sweet on cryptocurrency? What’s it like to be a Swiss expat in America? Swiss women couldn’t vote until when?!
While not at the forefront in developing vaccines, Swiss companies have been stepping up their involvement in manufacturing Covid-19 vaccines. Lonza is producing ingredients for the Moderna vaccine at its production plant in Visp, southern Switzerland, while pharma giant Novartis has signed deals to help manufacture both the Pfizer/BioNtech and CureVac vaccines. Roche has been focusing on Covid-19 tests and treatments.
The question of whether Switzerland should have developed its own Covid vaccines has been in the headlines in recent weeks. Swiss Health Minister Alain Berset has been caught up in a controversy for reportedly turning down an offer by Lonza to produce vaccines domestically.
Newspapers have claimed that in spring 2020 Berset missed the chance to secure a Swiss-based vaccine production line via Lonza. Berset has since said there was no clear connection between investing in Lonza and securing access to the Moderna vaccine.
A parliamentary commission plans to investigate the matter. It’s not known when their findings will be published.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Study: high pollen concentrations increase blood pressure
This content was published on
A high concentration of pollen can increase blood pressure in allergy sufferers, according to a Swiss study. The effect is much more pronounced in women and people who are overweight.
New asylum regulations come into effect in Switzerland
This content was published on
Several asylum-related changes come into effect in Switzerland on June 1 aimed at improving the employment and housing situations of refugees.
Swiss unions call for CHF5,000 monthly salary for qualified apprentices
This content was published on
All workers who have completed an apprenticeship should earn at least CHF5,000 per month, the Swiss Trade Union Federation said on Friday.
Flooding risks in parts of Switzerland and Germany after heavy rains
This content was published on
There is a significant risk of flooding on the River Rhine from Lake Constance to Basel and on the Thur River in canton Thurgau in eastern Switzerland.
Switzerland to intensify border checks during sporting events
This content was published on
In the context of events including the European Football Championships and the summer Olympics, border security will be increased.
Integration of Credit Suisse into UBS now complete
This content was published on
Credit Suisse AG was formally integrated into UBS AG on Friday, with the former being subsequently deleted from Canton Zurich's commercial register.
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
Switzerland mulls future European coordination on medical supplies
This content was published on
“The pandemic has shown us that we are very dependent, maybe too much so, on other markets,” Swiss President Guy Parmelin has said.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.